U.S. Stocks Movement: Oruka Therapeutics Plunges on October 6 Due to Financing Dilution, Selling Pressure, and High-Level Correction
Bitget异动解读2026/10/06 14:40Oruka Therapeutics October 6 Major Drop Analysis
Keywords: financing dilution, selling pressure, correction from highs
1. As of October 6, 2026, after a cumulative increase of 158.73% for the year, the stock price was at a high level and declined 4.54% over the past five trading days, with short-term profit-taking accelerating the correction.
2. On August 21, 2026, the company filed a mixed securities shelf registration statement of up to $1 billion, indicating that future financing might increase share supply and bring potential dilution pressure.
3. On September 21, 2026, the company's General Counsel sold 10 thousand shares; on September 23, 2026, Fairmount reportedly sold approximately 3.55 million shares, adding to the supply pressure on the stock.
4. On September 23, 2026, ORKA-001 announced 28-week data, showing efficacy improvements, but the incidence of upper respiratory tract infections was 8%, and two serious adverse events were reported; full 52-week data is not expected until December 2026, and long-term safety and sustained efficacy have not yet been fully verified.
(Disclaimer: This content is generated by AI technology based on publicly available information. For reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Spot gold in New York closed down 0.58% at $4,163.20.
At the close of trading in New York on Tuesday, October 6th, spot gold fell by 0.58% to $4,163.20 per ounce; spot silver rose by 0.44% to $61.3410 per ounce; and COMEX copper futures gained 0.24%, closing at $6.6570 per pound. Recently, the price fluctuations of precious and industrial metals have been closely correlated with global macroeconomic expectations, the performance of the US dollar, and changes in commodity supply and demand. The future price trends of these related categories will continue to be jointly influenced by factors such as the Federal Reserve’s monetary policy moves and the pace of manufacturing recovery in major global economies.
Updated Version 3 - Driven by strong demand from artificial intelligence data centers, Marvell raises its revenue forecast for 2028
In the third paragraph, CEO comments were added. Revenue for fiscal year 2031 is expected to reach $70 billion to $90 billion, surpassing market expectations. Custom chip revenue for fiscal year 2029 is projected to reach $12 billion. Executives attribute this optimistic outlook to the booming development of artificial intelligence and a decade of sustained effort. Prathik Jayaprakash/Anhata Rooprai/Max A. Cherney — Reuters, October 6 — Marvell Technology MRVL.O on Tuesday raised its revenue forecast for fiscal year 2028 to about $20 billion, above Wall Street expectations, due to surging demand for custom data center chips and a boom in AI-related spending. The Santa Clara, California-based company's stock rose about 6%, while shares of competitor Broadcom AVGO.O were up about 4%. “It took a very long time to put the company on this path and become a technology leader,” Marvell President and Chief Operating Officer Chris Koopmans said in an interview. “We have always had a track record of delivering on our commitments.” Marvell established a strategy in 2021 focusing on custom and cloud-optimized chips, specifically designed for data centers. Since then, the company has been one of the main beneficiaries of the AI infrastructure boom, and now expects to achieve $12 billion in custom chip revenue in fiscal 2029, up from its previous target of $10 billion. As technology companies develop proprietary AI processors to decrease reliance on Nvidia NVDA.O chips, Marvell’s custom chip business has become a primary growth driver. So far this year, Marvell's stock has surged more than threefold. In August, Marvell disclosed an agreement with Google's Alphabet GOOGL.O which could bring in up to $120 billion in sales through fiscal year 2033, pending certain business milestones. That same month, the company raised its full-year revenue forecast from $16.5 billion to about $18 billion. On Tuesday, Marvell forecast fiscal 2031 revenue between $70 billion and $90 billion. According to a Visible Alpha survey of four analysts, the midpoint of $80 billion exceeds Wall Street's expectation of $46.85 billion. According to London Stock Exchange Group (LSEG) data, analysts previously expected 2028 revenue to be $18.2 billion. (For the convenience of non-English speakers, Reuters provides automated translations of its reports into several other languages. As automated translation may contain errors or lack complete context, Reuters does not guarantee the accuracy of these translations and provides them solely for reader convenience. Reuters accepts no liability for any damages or losses caused by the use of automated translation functionality.)

The Dow Jones, Nasdaq, and S&P 500 all closed higher, with the S&P rising 0.58%.
The Dow Jones closed up 0.49%, the Nasdaq rose 0.45%, and the S&P 500 gained 0.58%. Among the most actively traded stocks, Nvidia was up 0.14%, Micron Technology fell 1.73%, SpaceX was up 0.49%, and Super Micro Computer rose 2.8%.
The French government plans to bypass parliament to push forward a spending cut plan worth several billions of euros.
According to market sources, the French Finance Minister stated that the government intends to bypass parliament to implement a spending cut plan worth several billions of euros.